Eisai plans drug delivery center to support biologics expansion Sandoz bags rights to generic Proventil from Kindeva Premas, Oramed unite to found oral COVID-19 vaccine startup Chiasma posts data on benefits of oral acromegaly drug over long-acting injectable rivals Biotech's top 10 money raisers of 2020 Featured Story | By Nick Paul Taylor Eisai has started construction of a new building to support the development and manufacturing of injectable formulations. The expansion is intended to support the broadening of Eisai’s focus beyond small molecules and into modalities that are delivered via injection. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor Sandoz has in-licensed commercial distribution rights to brand and authorized generic Proventil HFA from Kindeva Drug Delivery. The deal positions Novartis’ Sandoz to compete for the U.S. market for albuterol medicines used in the treatment of wheezing and shortness of breath. read more By Nick Paul Taylor Premas Biotech and Oramed have joined forces to start an oral COVID-19 vaccine startup, Oravax Medical. The biotech starts life with exclusive licenses from both companies and plans to get into the clinic in the second quarter. read more By Nick Paul Taylor Chiasma has released phase 3 data supporting its belief that acromegaly patients will prefer to take its oral formulation over existing long-acting injectables. read more By Amirah Al Idrus Private biopharma companies raised nearly $20 billion in 2020, blowing past the record $17.9 billion set in 2018. Here are the top 10 fundraising rounds, which include some "truly monstrous" financings like Sana Biotechnology's eye-watering $700 million series and Lyell Immunopharma's $493 million raise. read more Resources Sponsored By: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored By: OCT Clinical Find out why more than 400 clinical trials annually are initiated in Russia by US and EU pharma in the free annual report by OCT Clinical. Sponsored By: Almac Clinical Technologies This industry report reveals qualitative and quantitative candid insight from clinical development insiders and their views on current clinical trial challenges faced amidst uncertainty. Sponsored By: Remarque Systems Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. Sponsored By: AmerisourceBergen Corporation Unlock product potential by making the most of your commercialization investments. Sponsored By: Acorn AI Unlock competitive advantage with AI and advanced analytics. Sponsored By: EVERSANA Mature brands lost billions in revenue and value during COVID, but with the right strategy, pharma can rebound and reignite revenue. Learn How. Sponsored By: BC Platforms Those wishing to unlock RWD’s true value must have access to a variety of data sources/types and the technological capabilities to use the data to uncover meaningful insights. Sponsored By: Thermo Fisher Scientific Involved in vaccine development? Check out this timely infographic detailing the history of vaccines, key development milestones, and what challenges remain. Sponsored By: Blue Matter, strategic consultants in the life sciences A look ahead at how cell-based therapies in oncology will advance during 2021-22: research, regulatory, and commercial milestones. Sponsored By: Baxter BioPharma Solutions While service directories are filled with CMOs claiming vaccine fill-finish experience, the logistical challenges resulting from seasonal product are unique and it is important that outsourcing partners can ensure quality and on-time delivery. Sponsored By: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored By: Within3 We enable virtual work — offering over-time sessions where participants are more focused, insights are more diverse and business goals are met. Sponsored by: Catalent Discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes. Sponsored by: Catalent This eBook features insights from experts in the industry on patient-centric drug development challenges and strategies on advancing drug design and development effectively. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Catalent In this webinar, pharmaceutical scientists present real-life examples of challenges they’ve overcome in the transfer of oral small molecules from a dedicated early-phase development site to a dedicated late-phase manufacturing site. BD&L Summit for Life Sciences March 9–10, 2021 | Virtual Event Global Clinical Quality April 7-8, 2021 | Virtual Event Neuroprotection: Opportunities in Retinal Neurodegenerative Diseases April 13, 2021 | 1:15p.m. ET / 10:15a.m. PT Pharma PR & Communications Virtual Summit April 20–22, 2021 | Virtual Event Learn core elements: pricing, competitive assessments and epidemiology April 28-29, 2021 | 9:00am-3:30pm PST
| 